Viking Therapeutics (VKTX) Operating Leases (2019 - 2026)
Viking Therapeutics (VKTX) posted Operating Leases of $3.93 million for Q2 2026, up 857.3% from $410,000 a year earlier.
Analysis
Viking Therapeutics (VKTX) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2024, Viking Therapeutics' Operating Leases came in at $630,000, down 32.7% from FY2023.
- Annual Operating Leases shows a five-year compound annual growth rate of 11.8% (FY2019 to FY2024).
- In prior years, Viking Therapeutics' Operating Leases was $936,000 in FY2023 (-25.7%), $1.26 million in FY2022 and $29,000 in FY2020 (-91.9%).
- The Q2 2026 figure stands as the highest quarterly Operating Leases in data going back to Q1 2019.
- On a year-over-year basis, Operating Leases increased in 1 of the last six quarters, with growth averaging 108.9%.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q2 2026, with growth of 857.3%; the weakest was Q3 2025, with a decline of 57.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.96 Bn | 1,103.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.51 Bn | 535.04 Bn | 17.26 Bn |
| 3 | AbbVie | 501.10 Bn | 474.21 Bn | 12.70 Bn |
| 4 | Merck | 367.09 Bn | 321.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.10 Bn | 262.09 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.72 Bn | 235.40 Bn | 12.86 Bn |
| 7 | Amgen | 235.73 Bn | 191.13 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.64 Bn | 164.84 Bn | 6.22 Bn |
| 9 | Pfizer | 169.63 Bn | 116.28 Bn | 10.94 Bn |
| 10 | Viking Therapeutics | 3.10 Bn | 578.92 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.93 Mn |
| Sep 30, 2025 | 318,000.00 |
| Jun 30, 2025 | 410,000.00 |
| Mar 31, 2025 | 502,000.00 |
| Dec 31, 2024 | 630,000.00 |
| Sep 30, 2024 | 755,000.00 |
| Jun 30, 2024 | 766,000.00 |
| Mar 31, 2024 | 852,000.00 |
| Dec 31, 2023 | 936,000.00 |
| Sep 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | 1.26 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 1.41 Mn |
| Mar 31, 2022 | 1.49 Mn |
| Dec 31, 2020 | 29,000.00 |
| Sep 30, 2020 | 115,000.00 |
| Jun 30, 2020 | 198,000.00 |
| Mar 31, 2020 | 279,000.00 |
API Access
Viking Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=VKTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();